New NIH Grant to Help Kashuba Target HIV Reservoirs New NIH Grant to Help Kashuba Target HIV Reservoirs The $4.4 million, five-year award will support the efforts of Kashuba's group in identifying which anti-HIV drugs get into tissues best and what mechanisms they use to do so.
Researchers Probe Immune Function to Determine Nanoparticle-Drug Dose Researchers Probe Immune Function to Determine Nanoparticle-Drug Dose Bill Zamboni, PhD, and a UNC team have created a probe to predict the clearance rates for nanoparticle drugs for individual patients, promising better efficacy and fewer side effects for drugs like Doxil.
New Leadership, Emphasis, and Name for UNC Pharmacogenomics Center New Leadership, Emphasis, and Name for UNC Pharmacogenomics Center Tim Wiltshire is the new director of the School's Center for Pharmacogenomics and Individualized Therapy. Federico Innocenti will serve as associate director. CPIT pursues genetic research aimed at getting patients the best results from medicines.
PhD Alum's Review Informs FDA Recommendation on Brisdelle PhD Alum's Review Informs FDA Recommendation on Brisdelle Recent graduate Dan Hertz's paper was cited in the FDA's ruling that Brisdelle's label should recommend prescribers to weigh the drug's benefits against the risk of possible interaction with a breast-cancer drug.
Dupuis Promoted to Clinical Professor Dupuis Promoted to Clinical Professor Bob Dupuis, PharmD, has been with the School for nearly thirty years and has directed the School's clinical fellowship program since 2006.
office

Arlo Brown
Assistant to Division Chair
arlob@email.unc.edu
919-962-0073
Kerr 3209
CB# 7569
Chapel Hill, NC 27599-7569